4D Molecular Therapeutics (FDMT) Prepaid Assets (2019 - 2026)

4D Molecular Therapeutics (FDMT) has 8 years of Prepaid Assets data on file, last reported at $14.5 million in Q1 2026.

• Prepaid Assets for Q1 2026 came in at $14.5 million, up 30.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.5 million (up 30.04% YoY), and the FY2025 annual result was $10.5 million, up 4.22% from the prior year.
• Prepaid Assets rose to $14.5 million in Q1 2026 per FDMT's latest filing, from $10.5 million in the prior quarter.
• Over five years, Prepaid Assets peaked at $14.5 million in Q1 2026 and troughed at $4.8 million in Q3 2022.
• A 5-year average of $8.7 million and a median of $8.6 million in 2023 frame the typical range for Prepaid Assets.
• On a YoY basis, Prepaid Assets climbed as much as 87.8% in 2022 and fell as far as 17.73% in 2022.
• A 5-year view of Prepaid Assets shows it stood at $7.0 million in 2022, then climbed by 20.11% to $8.4 million in 2023, then gained by 20.33% to $10.1 million in 2024, then gained by 4.22% to $10.5 million in 2025, then jumped by 38.1% to $14.5 million in 2026.
• Business Quant data shows FDMT's Prepaid Assets at $14.5 million in Q1 2026, $10.5 million in Q4 2025, and $7.3 million in Q3 2025.